{
    "clinical_study": {
        "@rank": "97607", 
        "arm_group": {
            "arm_group_label": "755nm Alexandrite laser with cap array", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess treatment of facial rejuvenation using the standard\n      hand piece and a Lens Array for the 755nm Alexandrite laser."
        }, 
        "brief_title": "Clinical and Histological Evaluation of the Picosure 755nm Laser With Cap Array for Facial Rejuvenation", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Facial Rejuvenation", 
        "condition_browse": {
            "mesh_term": "Facies"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Is a healthy male or female between 18 and 65 years old\n\n          2. Is willing to consent to participate in the study.\n\n          3. Is willing to comply with all requirements of the study including biopsies, being\n             photographed, following post treatment care and attending all treatment and follow up\n             visits.\n\n        Exclusion Criteria:\n\n          1. The subject is female and pregnant, has been pregnant within the last 3 months, is\n             currently breast feeding or planning a pregnancy during the study period.\n\n          2. The subject is hypersensitive to light exposure OR takes photo sensitized medication.\n\n          3. The subject has active or localized systemic infections.\n\n          4. The subject has a coagulation disorder or is currently using anti-coagulation\n             medication (including but not limited to heavy aspirin therapy {greater than 81 mg\n             per day}).\n\n          5. The subject has any condition which, in the investigator's opinion, would make it\n             unsafe for the subject to participate in this research study.\n\n          6. The subject is currently enrolled in an investigational drug or device trial, or has\n             received an investigational drug or been treated with an investigational device\n             within 3 months prior to entering this study.\n\n          7. The subject has used Accutane within 6 months prior to enrollment.\n\n          8. The subject has the need to be exposed to artificial tanning devices or excessive\n             sunlight during the trial.\n\n          9. The subject has had prior treatment with parenteral gold therapy (gold sodium\n             thiomalate).\n\n         10. The subject has a history of keloids.\n\n         11. The subject has evidence of compromised wound healing.\n\n         12. The subject has a history of squamous cell carcinoma or melanoma.\n\n         13. The subject has a history of immunosuppression/immune deficiency disorders (including\n             HIV infection or AIDS) or use of immunosuppressive medications.\n\n         14. The subject has an allergy to lidocaine and epinephrine."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 31, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02107157", 
            "org_study_id": "CYN13-PICO-CAPHST-ET"
        }, 
        "intervention": {
            "arm_group_label": "755nm Alexandrite laser with cap array", 
            "intervention_name": "755nm Laser with Cap Array", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 4, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Sacramento", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "95819"
                }, 
                "name": "Dermatology and Laser Surgery"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Clinical and Histological Evaluation of the Picosure 755nm Laser With Cap Array for Facial Rejuvenation", 
        "other_outcome": [
            {
                "measure": "Record Investigator satisfaction per questionnaire", 
                "safety_issue": "No", 
                "time_frame": "3 months post treatment"
            }, 
            {
                "measure": "Record subject satisfaction per questionnaire", 
                "safety_issue": "No", 
                "time_frame": "3 months post treatment"
            }
        ], 
        "overall_official": {
            "affiliation": "Cynosure, Inc.", 
            "last_name": "Patricia Krantz", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Subjects will have one 3mm punch biopsy obtained pretreatment from an inconspicuous area and subsequent biopsies at one or any of the following visits after treatment.", 
            "measure": "Evaluate histological data for signs of new collagan generations based on biopsies.", 
            "safety_issue": "Yes", 
            "time_frame": "3 months post treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02107157"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Assessments will be conducted at the Baseline, 1 month and 3 month treatment follow up visits.", 
            "measure": "Assess the subject's level of photoaging using the Overall Integrated Assessment of Photodamage Scale", 
            "safety_issue": "No", 
            "time_frame": "3 months post treatment"
        }, 
        "source": "Cynosure, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cynosure, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}